BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31796878)

  • 21. Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle.
    Flores-Alcantar A; Gonzalez-Sandoval A; Escalante-Alcalde D; Lomelí H
    Cell Tissue Res; 2011 Jul; 345(1):137-48. PubMed ID: 21647563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid-type poorly differentiated adenocarcinoma of the stomach: Deficiency of mismatch repair and SWI/SNF complex.
    Tsuruta S; Kohashi K; Yamada Y; Fujiwara M; Koga Y; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
    Cancer Sci; 2020 Mar; 111(3):1008-1019. PubMed ID: 31922331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.
    Cajuso T; Hänninen UA; Kondelin J; Gylfe AE; Tanskanen T; Katainen R; Pitkänen E; Ristolainen H; Kaasinen E; Taipale M; Taipale J; Böhm J; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P
    Int J Cancer; 2014 Aug; 135(3):611-23. PubMed ID: 24382590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered ARID1A expression in colorectal cancer.
    Erfani M; Hosseini SV; Mokhtari M; Zamani M; Tahmasebi K; Alizadeh Naini M; Taghavi A; Carethers JM; Koi M; Brim H; Mokarram P; Ashktorab H
    BMC Cancer; 2020 Apr; 20(1):350. PubMed ID: 32334542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer.
    Hu W; Lei L; Xie X; Huang L; Cui Q; Dang T; Liu GL; Li Y; Sun X; Zhou Z
    Cell Death Dis; 2019 Jul; 10(8):550. PubMed ID: 31320608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
    Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
    Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective vulnerability of ARID1A deficient colon cancer cells to combined radiation and ATR-inhibitor therapy.
    Xu S; Sak A; Niedermaier B; Erol YB; Groneberg M; Mladenov E; Kang M; Iliakis G; Stuschke M
    Front Oncol; 2022; 12():999626. PubMed ID: 36249060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes.
    Raab JR; Resnick S; Magnuson T
    PLoS Genet; 2015 Dec; 11(12):e1005748. PubMed ID: 26716708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair.
    Luoto KR; Meng AX; Wasylishen AR; Zhao H; Coackley CL; Penn LZ; Bristow RG
    Cancer Res; 2010 Nov; 70(21):8748-59. PubMed ID: 20940401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death.
    Ye Y; Xiao Y; Wang W; Wang Q; Yearsley K; Wani AA; Yan Q; Gao JX; Shetuni BS; Barsky SH
    Mol Cancer Res; 2009 Dec; 7(12):1984-99. PubMed ID: 19996304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Oncogenic Super-Enhancers Is Coupled with DNA Repair by RAD51.
    Hazan I; Monin J; Bouwman BAM; Crosetto N; Aqeilan RI
    Cell Rep; 2019 Oct; 29(3):560-572.e4. PubMed ID: 31618627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.
    Raab JR; Runge JS; Spear CC; Magnuson T
    Epigenetics Chromatin; 2017 Dec; 10(1):62. PubMed ID: 29273066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depletion of Akt1 and Akt2 Impairs the Repair of Radiation-Induced DNA Double Strand Breaks via Homologous Recombination.
    Mohammadian Gol T; Rodemann HP; Dittmann K
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting ARID1A mutations in cancer.
    Mullen J; Kato S; Sicklick JK; Kurzrock R
    Cancer Treat Rev; 2021 Nov; 100():102287. PubMed ID: 34619527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of MDC1 and 53BP1 by short hairpin RNA enhances radiosensitivity in laryngeal carcinoma cells.
    Gou Q; Xie Y; Liu L; Xie K; Wu Y; Wang Q; Wang Z; Li P
    Oncol Rep; 2015 Jul; 34(1):251-7. PubMed ID: 25976740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
    Veuger SJ; Durkacz BW
    DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines.
    Sak A; Stueben G; Groneberg M; Böcker W; Stuschke M
    Br J Cancer; 2005 Mar; 92(6):1089-97. PubMed ID: 15785736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response.
    Mandal J; Mandal P; Wang TL; Shih IM
    J Biomed Sci; 2022 Sep; 29(1):71. PubMed ID: 36123603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies.
    Caumanns JJ; Wisman GBA; Berns K; van der Zee AGJ; de Jong S
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):176-184. PubMed ID: 30025943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mRNA Display Identifies Potent, Paralog-Selective Peptidic Ligands for ARID1B.
    Cremosnik GS; Mesrouze Y; Zueger P; Furkert D; Grandjean F; Argoti D; Mermet-Meillon F; Bauer MR; Brittain S; Rogemoser P; Yang W; Giovannoni J; McGregor L; Tang J; Knapp M; Holzinger S; Buhr S; Muller L; Leder L; Xie L; Fernandez C; Nieto-Oberhuber C; Chène P; Galli GG; Sesterhenn F
    ACS Chem Biol; 2024 May; 19(5):1142-1150. PubMed ID: 38655884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.